Case 3: Chronic Breathlessness Flashcards

1
Q

Sympathetic innervation of bronchiolar smooth muscle is mediated by

A

noradrenaline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Sympathetic innervation of bronchiolar smooth muscle is mediated by noradrenaline acting on beta receptors to cause

A

bonchodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

parasymp on lungs

A

bronchoconstriciton

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

parasymp receptor and agonist in lungs

A

acH on muscarinic causes bronchoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

type 1 alveolar cells

A

simple squamous cells where gas exchange occurs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

type 11 alveolar cells

A

synthesis of surfactant ….10% of cells in alveolar small cuboidal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pneumocytes

A

alveolar cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

pulmonary arteries supply

A

deoxygenated blood from the right ventricle to the alveolar capillary network

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pulmonary veins carry

A

oxygenated blood from lungs to left atrium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

the bronchial arteries supply oxygenated blood from the thoracic aorta to the

A

lung tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

the bronchial veins drain deoxygenated blood to the

A

pulmonary and systemic venous systems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what conditions do you see breathlessness Variation in symptoms at different times of day

A

Answer(s): Asthma, Asthma/COPD overlap syndrome, Anxiety
Explanation: Diurnal variation in symptoms is a classic feature of asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what conditions do you see Night time symptoms breathlessness

A

Answer(s): Asthma, Asthma/COPD overlap syndrome
Explanation: Nocturnal symptoms are a classic feature of asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what conditions do you see symptoms when lying flat breathlessness

A

cardiac pathology
Explanation: Orthopnoea is a feature of congestive cardiac failure. The doctor could also have asked about paroxysmal nocturnal dyspnoea.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what conditions do you see ankle swelling breathlessness

A

Answer(s): Cardiac pathology, Pulmonary embolism
Explanation: Bilateral ankle swelling is a sign of cardiac pathology, especially congestive cardiac failure. Unilateral ankle swelling may be an indication of DVT/PE.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what conditions do you see chest pain breathlessness

A

Answer(s): Cardiac pathology, Pulmonary embolism
Explanation: If the patient answered ‘yes’ to this, you would want to explore this symptom further (for example using a SOCRATES approach) to help determine the likely cause of this pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what conditions do you see Faintness/lightheadedness breathlessness

A

Answer(s): Cardiac pathology, Anxiety
Explanation: Cardiac pathology and very classically aortic stenosis can cause breathlessness with lightheadedness. Anxiety may result in lightheadedness or hyperventilation with tingling numbness around the mouth.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what conditions do you see Occupational history breathlessness

A

Answer(s): Occupational diseases, Asthma, Hypersensitivity pneumonitis
Explanation: There are a number of lung diseases associated with occupational exposure that need to be considered where appropriate. For example, coal miner’s pneumoconiosis, silicosis, beryllisosis, Farmer’s lung (a hypersensitivity pneumonitis). Occupational asthma is a type of asthma caused by exposure to inhaled irritants in the workplace.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what conditions do you see if you have had exposure to asbestos breathlessness

A

Answer(s): Asbestosis, Malignancy
Explanation: It is well documented that women exposed to asbestos by laundering their husband’s work clothes are at risk of asbestosis and mesothelioma. Asbestos exposure also increases the risk of lung cancer, in particular adenocarcinoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what conditions cause breathlessness due to pets

A

Answer(s): Asthma, Hypersensitivity pneumonitis
Explanation: Asking about pets and exposure to potential asthma-triggering allergens is important in a breathlessness history. Exposure to birds can also cause hypersensitivity pneumonitis in some people.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what condition causes breathlessness due to birds

A

Answer(s): Hypersensitivity pneumonitis
Explanation: A type of hypersensitivity pneumonitis due secondary to repeated inhalation of avian antigens is seen in bird keepers (sometimes known as ‘Pigeon Fancier’s Lung’).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what conditions causes breathlessness due to smoking

A

Answer(s): COPD, Malignancy, Cardiac Pathology
Smoking is a risk factor for many respiratory and cardiac pathologies and should always be asked about.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

acute and chronic findings of hypersensitivity pneumonitis

A

Inhaled antigenic organic dusts: Farmer’s lung (moldy hay). Humidifier lung (thermophilic bacteria). Bird-fancier’s lung (avian proteins). Acute and chronic forms. Chronic disease findings: Interlobular and intralobular interstitial thickening. Honeycombing, Traction bronchiectasis. May spare costophrenic angles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

hemoptysis respiratory history

A

Haemoptysis is always useful to ask about when taking a respiratory history and is associated with a number of pathologies including lung cancer, tuberculosis and pulmonary embolism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

smoking history

A

Mrs Smith may well have a smoking-related lung disease, therefore it is very important to take a smoking history and to take the opportunity to make every contact count (I.e. have opportunistic conversations about behaviour change). Taking a detailed smoking history entails finding out the following information.
- Are they a current smoker?
- What age did they start smoking?
- Do they smoke cigarettes or roll-ups?
- How many cigarettes a day do they smoke? (If they smoke roll-ups, how much tobacco is used in a week? - half an ounce of tobacco is around 20 cigarettes.)
- Have they ever smoked more or less than they do now?
- Any breaks from smoking?
- Have they ever tried to give up? What was helpful? What were the challenges? Why did they start again?
- Have they tried nicotine replacement therapy before?
- Does anyone else in the house smoke, i.e., are they a passive smoker (living with other people who smoke also makes it more difficult to quit)?
- Is quitting smoking something they would consider now?
In consultations where smoking is important, but time is very short, we recommend the approach of ‘Ask, Advise, Act.’ For more information and a short e-learning package see the National Centre for Smoking Cessation and Training’s ‘Very Brief Advice on Smoking’.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what causes hyper inflated chest and conditions you see it in

A

Hyperinflated lungs can be caused by blockages in the air passages or by air sacs that are less elastic, which interferes with the expulsion of air from the lungs. Hyperinflated lungs are often seen in people with chronic obstructive pulmonary disease (COPD) — a disorder that includes emphysema.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

polyphonic expiratory wheeze

A

Polyphonic wheezing consists of multiple musical notes starting and ending at the same time and is typically produced by the dynamic compression of the large, more central airways. Polyphonic wheeze is confined to the expiratory phase only.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Asthma vs COPD

A

Asthma usually involves acute (temporary) increases in airway resistance whereas COPDs are associated with chronic (long-lasting) increases in airway resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

findings in COPD CXR

A

hyperinflation, flattened diaphragm, enlarged retrosternal space, dec. pulmonary vascular markings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

LFT and COPD

A

Lung function tests (spirometry) are the only investigations that can definitively diagnose COPD, and can also determine whether there is any element of reversibility and enable classification of severity of COPD. It might alternatively reveal another diagnosis such as asthma or restrictive lung disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

D-dimer test

A

is a global marker of coagulation activation and measures fibrin degradation products produced from fibrinolysis (clot breakdown). The test is used for the diagnosis of DVT when the patient has few clinical signs and stratifies patients into a high-risk category for reoccurrence. Useful as an adjunct to noninvasive testing, a negative D-dimer test can exclude a DVT without an ultrasound.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

hallmark symptoms of COPD

A

Shortness of breath
Chronic cough
Sputum production
Other features include:
Winter exacerbations
Wheeze

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

extra signs of COPD

A

Tar-staining (fingers) – in developed countries, COPD is caused almost entirely by smoking but may also first present after an individual has stopped smoking
Chest hyperexpansion – a typical ‘barrel-shaped’ chest develops over time due to air trapping
Pursed lip breathing – this enables a patient to reduce their respiratory rate by increasing their period of expiration; it creates resistance to expiratory airflow and development of a positive expiratory pressure in the airways, reducing airway collapse and aiding ventilation
Accessory muscle use (neck/shoulder) – air trapping and hyperinflation impede effective chest expansion by the diaphragm and intercostal muscles, so the patient uses accessory muscles including the sternocleidomastoid, scalene, trapezius and abdominal muscles to aid ventilation
Peripheral oedema (ankles) – indicates right-sided heart failure due to cor pumonale
Palpable liver – may be due to hyperinflation of the lungs or congestive heart failure
Auscultation – you may hear reduced breath sounds, reduced heart sounds, tachypnoea and wheeze; during an exacerbation there may also be crepitations
Chest wall movement – reduced lateral (‘bucket handle’) chest expansion and increased vertical (‘pump handle’) chest expansion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

alpha-1 antitrypsin deficiency

A

Panacinar emphysema
Intrahepatic accumulation of AAT molecules leading to cirrhosis
PAS stain +

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

COPD inflammation

A

Inhalation of noxious particles
Mediators released cause damage to lung tissue.
Airways inflamed
Parenchyma destroyed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

goblet cell hyperplasia

A

causes sputum. COPD, also ariway narrowing and alveolar destruction - breathlessness and wheeze

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

gold standard for diagnosing COPD

A

Spirometry is the gold standard investigation for diagnosing COPD and grading severity of COPD. Spirometry machines measure the volume and flow rate of inspiration and expiration, and can therefore be used to diagnose obstructive and restrictive lung diseases. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) developed a classification system for severity of COPD disease based on spirometry. NICE guidelines were updated in 2018 to mirror this classification system.

mild >80%
moderate 50-80%
severe 30-50%
very severe <30%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

cardinal feature of COPD

A

airway obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

COPD FEV1/FVC

A

<70%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

why does Premature airway collapse happen in copd

A

structure damaged - airway not mantained

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

COPD staging

A

GOLD Criteria
FEV1/FVC of less than 70%

Then FEV1 of:

I (mild)- more than 80
II (mod)- 50-79
III (severe)- 30-50
IV (very severe)- less than 30

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Obstructive flow volume loop in spirometry

A

short and wide loop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Restrictive flow volume loop

A

skinny and tall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

COPD normal progression

A

Progressive decline in lung function
Progressive dyspnoea and disability
Right ventricular failure (‘cor pulmonale’)
Exacerbations become more frequent and contribute to morbidity and disability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

cor pulmonale

A

right ventricular hypertrophy and heart failure due to pulmonary hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

fundamentals of COPD care

A

no smoking
vaccinations
physio
personalized plan
comorbities treat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

COPD care

A

inhaled therapy oral add on
surgical therapy
oxygen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

smoking cessation drugs

A

Drugs that blunt cravings for nicotine, including buproprion and varenicline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

buproprion moa

A

inhibits reuptake of NE and dopamine
nicotinic antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

varenicline moa

A

partial agonist and antagonist at a4B2 nicotinic ACh receptors in the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

inhaled therapies for COPD

A

SABA beta two receptors - bronchodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

name some SABAs given to COPD patients

A

Albuterol
Levalbuterol
Pirbuterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

name a SAMA given to COPD patients

A

Ipratropium - Short acting muscarinic antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

what do we give for COPD treatment for those with no ashmatic features

A

LABA and LAMA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

LABAs given to COPD patients

A

Salmeterol
Formoterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

LAMAs given to COPD patients

A

Tiotropium
Aclidinium
Umeclidinium
Glycopyrrolate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

what do we give COPD patients with asthmatic features

A

LABA and ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

name some ICS inhalers

A

beclamethasone, fluticason, budesonide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Step 3 COPD Treatment

A

LABA + LAMA + ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

oral add ons COPD

A

theophylline, mucolytic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

name a mucolytic

A

Carbocisteine

62
Q

what is Theophylline

A

bronchodilator

63
Q

name some oral corticosteroids

A

prednisone, methylprednisolone

64
Q

oral corticosteroids MOA

A

Decrease inflammation by reducing the activity of the immune system

65
Q

Oxygen therapy for COPD

A

PaO2 < 55 mmHg (70%) or right hear failure, polycythemia, or impaired neuropsychiatric function, pulmonary hypertension
Generally stage IV
2 L/min

66
Q

polycythemia

A

A disorder characterized by an abnormal increase in the number of red blood cells in the blood

67
Q

Surgery for COPD

A

lung reduction surgery to remove damaged lung tissue or lung transplant

68
Q

Bullectomy

A

Used for emphysema
Large bullae are resected to improve lung function

69
Q

phenotype of patients who get exacerbations of COPD

A

can be pneumonia on CXR or not
bacteria or virus

70
Q

AE of COPD symptoms

A

runny nose
breathlessness
cough
sputum
sputum purulence
ankle swelling

71
Q

Coryzal symptoms

A

snotty/runny nose

72
Q

ae of COPD investigations

A

CXR ECG
gas exchange
FBC, U+E
CRP

73
Q

Management of COPD Exacerbations

A

SABAs (specifically inhaled, either alone or in combination with inhaled anticholinergics) are preferred for bronchodilation during COPD exacerbations
Systemic glucocorticoids
Antibiotics if purulent
Supplemental oxygen to maintain an oxygen saturation of 88% to 92%

74
Q

COPD blood gases

A

Arterial Blood Gases (ABGs)
- Arterial pO2 (80-100 mm Hg)
- Arterial pCO2 (35-45 mm Hg)

Hemoglobin O2 saturation
- SaO2 (95-100%)

type 1 and type 2 resp failure

75
Q

Type 1 respiratory failure

A

failure of oxygenation
PaO2 <8 (SaO2 <90%)
increased resp drive leads to increased ventilation
PCO2 drops
Causes include diffusion abnormalities, v/q mismatch, low inspired O2

ONE = Oxygen low, Not Equal V/Q

76
Q

Type 2 respiratory failure

A

failure of ventilation, cannot increase ventilation
PaO2 <8, pCO2 rises >6.7, pH falls <7.35
CO2 dissolves in blood to produce carbonic acid
Causes include airway obstruction, hyperexpanded lungs, thoracic cage problems, weaknesss of resp muscles

TWO = Thoracic cage probs/hyperexpansion, Weakness in muscles, Obstruction

77
Q

type 2 resp failure and copd

A

In COPD the elastic recoil of the lungs is lost. This causes gas trapping and reduced excretion of carbon dioxide. Sputum retention also means there is less surface area for gas exchange. In the blood, the carbon dioxide combines with water to form carbonic acid.
In an acute setting, the increased acid levels in the blood would lower the pH levels and the patient would become unwell very quickly.

However, when carbon dioxide retention is slowly progressive, as is often the case in chronic COPD, the body can compensate for this by utilising the bicarbonate buffer system of the blood. The kidneys are stimulated to reabsorb more bicarbonate, which acts as a base and neutralises the carbonic acid, thus restoring the pH back to the normal range.

78
Q

clinical features of hypercapnia

A

dilated pupils
altered mental state
asterixis
bounding pulse
tachyopnea
raised JVP
flushed skin

79
Q

nipple shadows

A

May be visible at the level of the fourth or fifth anterior rib spaces and may occasionally mimic nodules or masses in the chest. May be differentiated with markers or oblique projections of the chest
- google the image

80
Q

COPD on CXR

A

hyperinflation, flattened diaphragm, enlarged retrosternal space, dec. pulmonary vascular markings
- check google

81
Q

P pulmonale

A

RA enlargement, almost always related to pulmonary system; usually causes backup into the ventricle & atria, causing enlargement of atria

82
Q

COPD and cancer

A

The presence of emphysema has been shown to confer a significant risk of developing lung cancer, particularly squamous cell carcinoma and SCLC (20). Overall, people with COPD have an increased risk (4- to 6-fold) of developing lung cancer, independent of smoking history, age and sex

83
Q

nail clubbing associated with

A

Nail clubbing can be seen in lung cancer, suppurative lung diseases (bronchiectasis, cystic fibrosis) and interstitial lung diseases.

84
Q

nail clubbing mechanism

A

An increase in hypoxia may activate local vasodilators, consequently increasing blood flow to the distal portion of the digits; however, in most cases, hypoxia is absent in the presence of clubbing, and many diseases with noted hypoxia are not associated with clubbing

85
Q

interstitial lung disease

A

refers to a group of almost 200 disorders that cause inflammation and scarring of the alveoli and their supporting structures

86
Q

suspected interstitial lung disease investigations

A

HRCT and spirometry

87
Q

what is FEV1/FVC

A

Ratio that is useful in distinguishing between restrictive & obstructive diseases

88
Q

High FEV1/FVC indicates

A

restrictive disease

89
Q

Transfer factor

A

converts normal lymphocytes into antigen-sensitized cells

90
Q

FEV1 ILD

A

In ILD a restrictive pattern of lung function is seen. FVC and FEV1 are low but proportionally so, so that the FVC/FEV1 ratio remains normal. Lung volumes are also reduced, as is the transfer factor, which measures the lungs’ ability to ‘soak up’ oxygen.

91
Q

CT of interstitial lung disease

A

basal fibrosis
honeycombing

92
Q

honeycombing

A

small (6 to 10 mm) cystic spaces with thick (1 to 3 mm) walls. usually have shared walls . Usually in posterior subpleural regions. End-stage pulmonary fibrosis: IPF (UIP). Chronic hypersensitivity pneumonitis. Occasionally sarcoidosis. (google)

93
Q

what is pulmonary function test for ILD

A

FEV1

94
Q

transfer factor measurement

A

Normal DLCO: >75% of predicted, up to 140% Mild: 60% to LLN (lower limit of normal) Moderate: 40% to 60% Severe: <40
A gas transfer test measures how your lungs take up oxygen from the air you breathe. The result of the test is called the transfer factor, or sometimes the diffusing capacity.

95
Q

is Fibrosis is a cardinal feature of Interstitial Lung Disease?

A

No Different forms ILD can be categorised as primarily inflammatory or primarily fibrotic. The inflammatory conditions may eventually lead to fibrosis if left unchecked. Distinguishing between the two is important with respect to the treatments available.

96
Q

diagnosis of exclusion

A

elimination of all competing possibilities

97
Q

name some Idiopathic ILD

A

Idiopathic pulmonary fibrosis
sarcoidosis
cryptogenic organising pneumonia

98
Q

Known causes of interstitial lung disease

A

Occuptaional - asbestosis/silicosis
enviromental - hypersensitivities - pigeons
immune - connective tissue disease
smoking - DIP (Desquamative Interstitial Pneumonia) and RBILD (Respiratory bronchiolitis–associated interstitial lung disease)

99
Q

ILD patient history

A

Occupational history – asbestos exposure, stone working (silicosis), farmers (mould exposure)- Other environmental exposures – birds, hot tubs- Smoking history- Medication history – a thorough medication history is very important as a number of drugs are known precipitants of lung fibrosis- Symptoms and signs of connective tissue disease – Raynaud’s, swollen/stiff joints, dry eyes, dry mouth, mouth ulcers, photosensitive rash, skin changes, sclerodactyly, telangiectasia, periungal erythema, dysphagia- Their perspective: exploring what they think might be going on, any worries they have, or hopes for treatment – this provides space for this patient to be known as an individual, may give clues to uncovered aspects of the history and indicates how sharing information about diagnosis/next steps should be tailored. Gathering the patient perspective increases patient satisfaction, enables better treatment adherence, reduces medication prescribed, and reduces likelihood of mistakes.

100
Q

drugs that can cause ild

A

amiodarona, ntrifurantoin, digoxin

101
Q

Nitrofurantoin moa

A

Inhibits various bacterial enzymes and damages bacterial DNA

102
Q

treatment for ILD

A

antifibrotics, pulmonary rehabilitation, oxygen assesment

drugs extend life by 2-3 yrs

103
Q

antifibrotics

A

prevent lysis of fibrin. (Amicar)
pirfenidone, nintedanib

104
Q

antifibrotics side effects

A

Patients treated with pirfenidone or nintedanib have reported a number of different side-effects, the vast majority being gastrointestinal (nausea, dyspepsia, diarrhoea) and skin-related events (rash, photosensitivity reaction) in the case of pirfenidone, and mainly gastrointestinal (diarrhoea and vomiting)

105
Q

lymphadenopathy cxr

A

swollen
check google

106
Q

Sarcoidosis

A

chronic inflammatory disease in which small nodules (granulomas) develop in lungs, lymph nodes, and other organs

107
Q

lymphoma

A

malignant tumor of lymph nodes and lymph tissue

108
Q

sit lamp examination

A

stereoscopic magnified view of the anterior eye structures in detail, includes cornea

109
Q

uveitis

A

inflammation of the uvea causing swelling and irritation

110
Q

Uveoparotid fever
Heerfordt’s syndrome

A

acute uveitis, fever, parotid gland swelling

111
Q

features of neurosarcoidosis

A

4%- 7% of pts; CN lesions most common; Facial palsy (7th Cranial Nerve) most frequent presentation

It represents a form of neurosarcoidosis, and in some patients a facial palsy is also seen. It is a relatively rare acute presentation of sarcoidosis, although involvement of the eyes, nervous system or salivary glands in isolation all occur frequently in sarcoidosis.

112
Q

features of Acute sarcoidosis

A
  • Erythema Nodosum
  • Bilateral Hilar Lymphadenopathy
  • Arthritis
  • Uveitis, parotitis
  • Fever
113
Q

Sarcoidosis epidemiology

A

Younger black females in their 30s-40s

114
Q

Erythema nodosum

A

painful nodules on anterior shins due to subcutaneous inflammation

115
Q

Lofgren’s syndrome (presentation and epidemiology)

A

Presentation of Sarcoidosis
- Hilar lymphadenopathy
- Erythema nodosum
- Polyarthritis
- Fever

females
scandinaivan or irish women
HLA-B8 gene
will settle with NSAIDS

116
Q

sarcoidosis systems

A

order of commoness
resp
skin
eye
thoracic lymp
liver
spleen
neuro
cardiac

117
Q

Sarcoidosis dermatological symptoms

A

Dermatologic signs include rash, lesions, color change, and nodule formations just under the skin.

118
Q

sarcoidosis - ophthalmic manifestations

A

uveitis, corneal deposits, iritis, vitritis, synechiae

119
Q

reticuloendothelial sarcoidosis

A

peripheral lymphadenopathy, hepato and splenomegaly

120
Q

sarcoidosis musculoskeletal

A

arthitis acute, chronic with periosteal bone resoprtion

121
Q

exorcrine sarcoidosis

A

enlarged salivary glands, xerostomia

122
Q

xerostomia

A

dry mouth

123
Q

Sarcoidosis Cardiac Manifestations

A

arrythmia, pulonary hypertension, cor pulmonale

124
Q

renalsarcoidosis

A

hypercalculria, hypercalcaemia, neprhocalcinosis

125
Q

sarcoidosis nervous system

A

meningitis, cranial nerve pals, central DI, hypothalamic hypopituitarism

126
Q

hypothalamic hypopituitarism

A

Hypothalamic hypopituitarism is relatively rare cause of secondary adrenal deficiency which is often accompanied by severe hypoglycemia. Hydrocortisone replacement therapy is essential for this condition, but gastrointestinal symptom such as nausea and vomiting is not well-recognized adverse effect of hydrocortisone

127
Q

sarcoidosis staging

A
  1. Normal
  2. Hilar/Mediastinal Nodes only
  3. Nodes + Parenchyma Dz
  4. Parenchyma Only
  5. End stage fibrosis
128
Q

clinical presentation of sarcoidosis

A

persistent dry cough, eye and skin manifestations, weight loss, fatigue, night sweats, and erythema nodosum.

129
Q

lab tests for sarcoidosis

A

ESr raised
hypercalcaemia
ACE raised
hypercalcinuria
leukopenia

130
Q

transbronchial biopsy

A

A pulmonologist performs a diagnostic bronchoscopy with biopsy. The endoscope was introduced into the bronchus, and attachments were used to perforate the bronchial wall. Tissue was obtained and submitted to the pathologist, who identified it as “lung parenchyma.” What type of biopsy was performed?

131
Q

weaning off steroids

A

administering exogenous steroids causes suppression of endogenous cortisol production by the adrenal glands. Abrupt withdrawal of exogenous steroids can therefore precipitate an adrenal crisis. A gradual reduction in exogenous steroid dose enables the adrenal glands to resume their normal function.

132
Q

aims of sarcoidosis treatment

A

prevent organ damage
need to do LFT, ECG, eye check, neur test, calcium 24 hour

133
Q

first line treatment sarcoidosis

A

observational if mild. 0.5mg prednisolone 2-4 weeks, taper according to response

134
Q

Methotrexate moa

A

inhibits dihydrofolate reductase

135
Q

What is methotrexate?

A

antineoplastic, immunosuppressant to treat malignancies
chemotherapy, rheumatoid arthritis, psoriasis, and for abortions

136
Q

Bronchiectasis

A

Bronchiectasis is a chronic condition in which the bronchial tree becomes abnormally and irreversibly dilated. The bronchial walls become thickened and inflamed, leading to a build-up of excess mucus which can make the lungs vulnerable to infection.
Patients typically present with recurrent chest infections, persistent cough with sputum production, and shortness of breath.

137
Q

CXR features of bronchiectasis

A

ring shadow
consolidation
mucus plugging
tram track opacity
google or check onemed to see

138
Q

causes of non-CF bronchiectasis

A

Idiopathic (most common)
Post-infective – e.g., bacterial pneumonia, mycobacterial infection
Allergic – e.g., to mould or fungus, especially in allergic bronchopulmonary aspergillosis (ABPA)
Autoimmune – associations with connective tissue diseases and inflammatory bowel disease
Immunodeficiency – e.g., primary ciliary dyskinesia, primary immunodeficiency disorders, HIV/AIDs
Obstruction – secondary to severe asthma or COPD, or distal to a neoplasm or inhaled foreign body

139
Q

UK epidemiology bronchiectasis

A

An estimated 212,00 people in the UK are living with non-CF bronchiectasis
There is a female to male predominance
Incidence increases with age, with 60% of diagnoses made in the over-70 age group
Interestingly, bronchiectasis is more commonly diagnosed in the least deprived sections of the UK population, in contrast to other respiratory disorders

140
Q

bronchiectasis treatments

A

Physiotherapy and airway clearance techniques
Cough assist devices
Smoking cessation: it is important for healthcare professionals to know what services are available to refer patients to, do you know how to find this information?
Pneumococcal and annual influenza vaccinations
Treatment with short courses of antibiotics for exacerbations or chest infections
In rare cases surgery, for example a lobectomy if bronchiectasis is localised and symptoms are debilitating

141
Q

active cycle of breathing technique

A

Involves the pt going through phases of breathing control, thoracic expansion exercises, and a huff cough

142
Q

sail sign

A

The CXR shows volume loss of the left lung field and a dense triangular opacity overlying the cardiac shadow: this is known as the ‘sail sign’

143
Q

Mucus plugging

A

Retention of secretions resulting in full airway obstruction that can result in atelectasis and impaired oxygenation due to shunting

144
Q

atelectasis

A

collapsed lung; incomplete expansion of alveoli

145
Q

Exacerbation of bronchiectasis

A

An exacerbation of bronchiectasis is defined as deterioration in three or more of the following key respiratory symptoms for at least 48 hours:
- Cough- Sputum volume and/or consistency- Sputum purulence- Breathlessness and/or exercise tolerance- Fatigue and/or malaise- Haemoptysis
They are not always the result of acute infection, and antibiotics are not always indicated.

146
Q

prognosis of bronchiectasis

A

depends on the underlying cause/associated conditions

Bronchiectasis is an extremely variable disease, but most patients have few day-to-day symptoms and a normal life expectancy. Some patients have frequent chest infections or exacerbations, which may severely effect quality of life. More severe disease results in daily symptoms, progressive loss of lung function and a reduced life expectancy. Uncommon complications are the development of pulmonary hypertension and cor pulmonale. A rare but serious complication of bronchiectasis is massive haemoptysis.

147
Q

Signet ring sign

A

Bronchiectasis. Cross section of pulmonary artery branch adjacent to dilated, ring-shaped bronchus.Bronchus diameter exceeds adjacent artery’s
Image: Signet ring sign

148
Q

Bronchoscopy with biopsy EBUS

A

EBUS (endobronchial ultrasound) bronchoscopy is a procedure used to diagnose different types of lung disorders, including inflammation, infections or cancer. Performed by a pulmonologist, EBUS bronchoscopy uses a flexible tube that goes through your mouth and into your windpipe and lungs.

149
Q

LTOT

A

Long term oxygen therapy

150
Q

Aminophylline

A

Bronchodilator - Decreases SOB

Therapeutic levels 10-20 mcg/dl
TOXIC > 20

CANT MIX WITH ANYTHING